Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis
The Janus kinase (JAK) 1 and 2 inhibitor, ruxolitinib, was recently approved in Japan and has been effective in many patients with myelofibrosis (MF). Although the inhibitor decreases splenomegaly and relieves MF-related symptoms, allogeneic hematopoietic cell transplantation (HCT) remains as the on...
Main Authors: | Etsuko Matsubara, Jun Yamanouchi, Riko Kitazawa, Taichi Azuma, Hiroshi Fujiwara, Takaaki Hato, Masaki Yasukawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2016/8751329 |
Similar Items
-
The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis
by: Marco Pizzi, et al.
Published: (2016-09-01) -
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
by: Miyuki Tsutsui, et al.
Published: (2019-11-01) -
Palliative splenic irradiation in primary and post PV/ET myelofibrosis: outcomes and toxicity of three radiation schedules
by: Mario Federico, et al.
Published: (2009-05-01) -
Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
by: Lining Zhang, et al.
Published: (2020-02-01) -
Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
by: MV Barabanshchikova, et al.
Published: (2016-07-01)